Gerhard Wolber
About
Gerhard Wolber is a scholar working on Molecular Biology, Computational Theory and Mathematics and Pharmacology.
According to data from OpenAlex, Gerhard Wolber has authored 218 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Molecular Biology, 57 papers in Computational Theory and Mathematics and 32 papers in Pharmacology. Recurrent topics in Gerhard Wolber's work include Computational Drug Discovery Methods (57 papers), Receptor Mechanisms and Signaling (37 papers) and Neuropeptides and Animal Physiology (23 papers). Gerhard Wolber is often cited by papers focused on Computational Drug Discovery Methods (57 papers), Receptor Mechanisms and Signaling (37 papers) and Neuropeptides and Animal Physiology (23 papers). Gerhard Wolber collaborates with scholars based in Germany, Austria and Italy. Gerhard Wolber's co-authors include Thierry Langer, Johannes Kirchmair, Marcel Bermúdez, Patrick Markt, Daniela Schuster, Simona Distinto, Jérémie Mortier, Christian Laggner, Manuela S. Murgueitio and Christin Rakers and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.
In The Last Decade
Gerhard Wolber
209 papers receiving 7.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gerhard Wolber Germany | 42 | 4.5k | 2.7k | 1.8k | 1.1k | 758 | 218 | 8.0k | ||
| Thierry Langer Austria | 54 | 5.1k 1.1× | 3.7k 1.4× | 3.0k 1.6× | 1.4k 1.3× | 840 1.1× | 252 | 9.9k | ||
| Jason K. Perry United States | 28 | 5.5k 1.2× | 3.1k 1.2× | 1.9k 1.0× | 993 0.9× | 477 0.6× | 60 | 10.3k | ||
| David B. Ascher Australia | 46 | 6.9k 1.5× | 2.6k 1.0× | 1.7k 0.9× | 710 0.7× | 555 0.7× | 187 | 11.8k | ||
| Perry C. Francis United States | 8 | 4.9k 1.1× | 2.9k 1.1× | 1.7k 0.9× | 950 0.9× | 438 0.6× | 16 | 7.7k | ||
| Stefano Forli United States | 37 | 6.1k 1.4× | 2.6k 1.0× | 2.9k 1.6× | 963 0.9× | 545 0.7× | 96 | 10.7k | ||
| Jonathan B. Baell Australia | 39 | 5.1k 1.1× | 2.2k 0.8× | 2.5k 1.3× | 929 0.9× | 338 0.4× | 177 | 9.2k | ||
| György M. Keserű Hungary | 44 | 4.8k 1.1× | 2.8k 1.0× | 2.7k 1.5× | 639 0.6× | 619 0.8× | 304 | 8.7k | ||
| Mee Shelley Canada | 16 | 5.5k 1.2× | 3.0k 1.1× | 2.0k 1.1× | 975 0.9× | 451 0.6× | 37 | 9.0k | ||
| Leah L. Frye United States | 18 | 7.1k 1.6× | 3.8k 1.4× | 2.9k 1.6× | 1.4k 1.4× | 619 0.8× | 32 | 11.8k | ||
| Keith W. Ward United States | 29 | 3.5k 0.8× | 2.4k 0.9× | 2.6k 1.4× | 923 0.9× | 853 1.1× | 67 | 8.3k |
Countries citing papers authored by Gerhard Wolber
Since
Specialization
Citations
This map shows the geographic impact of Gerhard Wolber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerhard Wolber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerhard Wolber more than expected).
Fields of papers citing papers by Gerhard Wolber
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Gerhard Wolber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerhard Wolber. The network helps show where Gerhard Wolber may publish in the future.
Co-authorship network of co-authors of Gerhard Wolber
This figure shows the co-authorship network connecting the top 25 collaborators of Gerhard Wolber. A scholar is included among the top collaborators of Gerhard Wolber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerhard Wolber. Gerhard Wolber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Weindl, Günther, et al.. (2025). Structure-guided approaches to modulate endosomal toll-like receptors TLR7, TLR8 and TLR9: advances, challenges and therapeutic promise. Drug Discovery Today. 30(11). 104495–104495.
2.
Angelis, Yiannis S., P. Sakellariou, Annekathrin M. Keiler, et al.. (2025). Further Insights Into the Metabolism of LGD‐4033 in Human Urine. Part 2. A New Minor Metabolite With Antagonistic Activity on the Androgen Receptor Can Indicate Recent Substance Intake. Drug Testing and Analysis. 18(1). 159–169.
3.
Dengiz, Cagatay, Sun Huang, Gerald W. Zamponi, et al.. (2025). Synthesis, molecular modeling, DFT studies, and enantioseparation of tetrahydro-4H-chromene derivatives with calcium channel blocking activity. Journal of Molecular Structure. 1330. 141457–141457.
4.
Sosič, Izidor, et al.. (2025). Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists. Acta Pharmaceutica. 75(2). 159–183.
5.
Cho, Sung‐Woo, et al.. (2025). Structure-based virtual screening identifies potent CD28 inhibitors that suppress T cell co-stimulation in cellular and mucosal models. European Journal of Medicinal Chemistry. 300. 118194–118194.
6.
Adhikary, Partho P., Temilolu Idowu, Zheng Tan, et al.. (2024). Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases. EMBO Molecular Medicine. 16(7). 1630–1656.
7.
Calvo‐Barreiro, Laura, et al.. (2024). From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-3. ACS Medicinal Chemistry Letters. 15(11). 1884–1890.
8.
Dengiz, Cagatay, et al.. (2024). Synthesis, molecular modeling, DFT studies, and EPR analysis of 1,4-dihydropyridines as potential calcium channel blockers. Journal of Molecular Structure. 1307. 137983–137983.
9.
Calvo‐Barreiro, Laura, et al.. (2023). Discovery of ICOS‐Targeted Small Molecules Using Pharmacophore‐Based Screening. ChemMedChem. 18(23). e202300305–e202300305.
10.
Maccari, Rosanna, Gerhard Wolber, Francesco Balestri, et al.. (2023). Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors. European Journal of Medicinal Chemistry. 252. 115270–115270.
11.
Thieme, Detlef, et al.. (2022). Detection of 18‐methyl steroids: Case report on a forensic urine sample and corresponding dietary supplements. Drug Testing and Analysis. 14(11-12). 1864–1870.
12.
Doğan, Şengül Dilem, Miyase Gözde Gündüz, Zülbiye Kökbudak, et al.. (2021). Design, synthesis, antibacterial activity evaluation and molecular modeling studies of new sulfonamides containing a sulfathiazole moiety. New Journal of Chemistry. 45(18). 8166–8177.
13.
Ottanà, Rosaria, Paolo Paoli, Mario Cappiello, et al.. (2021). In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications—A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B. Molecules. 26(2). 330–330.
14.
Machalz, David, et al.. (2021). Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase. Frontiers in Endocrinology. 12. 633785–633785.
15.
Bermúdez, Marcel, Andreas Ritsch, Sándor Hosztafi, et al.. (2020). N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists. Scientific Reports. 10(1). 5653–5653.
16.
Bermúdez, Marcel, et al.. (2017). Nuclear transport of the human aryl hydrocarbon receptor and subsequent gene induction relies on its residue histidine 291. Archives of Toxicology. 92(3). 1151–1160.
17.
Nizami, Bilal, Dominique Sydow, Gerhard Wolber, & Bahareh Honarparvar. (2016). Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: molecular dynamics simulations and dynamic pharmacophore analysis. Molecular BioSystems. 12(11). 3385–3395.
18.
Ottanà, Rosaria, Paolo Paoli, Giulia Lori, et al.. (2016). Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents. European Journal of Medicinal Chemistry. 127. 840–858.
19.
Becker, Daniel P., Zuzanna Kaczmarska, Christoph Arkona, et al.. (2016). Irreversible inhibitors of the 3C protease of Coxsackie virus through templated assembly of protein-binding fragments. Nature Communications. 7(1). 12761–12761.
20.
Papadakis, Emmanouil, M. Salomé Gachet, Martin Deutsch, et al.. (2013). Isolation of a Novel Thioflavin S–Derived Compound That Inhibits BAG-1–Mediated Protein Interactions and Targets BRAF Inhibitor–Resistant Cell Lines. Molecular Cancer Therapeutics. 12(11). 2400–2414.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Thierry Langer Breakdown of academic impact, for papers by Jason K. Perry Breakdown of academic impact, for papers by David B. Ascher Breakdown of academic impact, for papers by Perry C. Francis Breakdown of academic impact, for papers by Stefano Forli Breakdown of academic impact, for papers by Jonathan B. Baell Breakdown of academic impact, for papers by György M. Keserű Breakdown of academic impact, for papers by Mee Shelley Breakdown of academic impact, for papers by Leah L. Frye Breakdown of academic impact, for papers by Keith W. Ward